Skip to main content

Table 2 Relationship between CCNI2 expression and tumor characteristics in patients with gastric cancer

From: CCNI2 promotes the progression of human gastric cancer through HDGF

Features

No. of patients

CCNI2 expression

p value

Low

High

All patients

93

50

43

 

Age (years)

   

0.331

  < 64

44

26

18

 

   ≥ 64

49

24

25

 

Gender

   

0.465

  Male

62

35

27

 

  Female

31

15

16

 

T Infiltrate

   

0.201

  T1

6

4

2

 

  T2

12

9

3

 

  T3

55

27

28

 

  T4

20

10

10

 

Lymphatic metastasis (N)

   

0.475

  N0

14

12

2

 

  N1

14

6

8

 

  N2

20

7

13

 

  N3

45

25

20

 

Stage

   

0.020

  I

5

4

1

 

  II

22

17

5

 

  III

63

26

37

 

  IV

3

3

0

 

Tumor size

   

0.960

   < 5 cm

38

20

18

 

   ≥ 5 cm

48

25

23

 

Lymph node positive

   

0.911

   ≤ 6

47

25

22

 

   > 6

46

25

21

 

Vessel carcinoma embolus

   

0.879

  0

15

8

7

 

  1

54

30

24

 

Nerve tumor infiltrates

   

0.884

  0

21

10

11

 

  1

18

9

9

 

Expression of CD34

   

0.888

  No

10

6

4

 

  Yes

32

20

12

 

Expression of EGFR

   

0.274

  No

69

38

31

 

  Yes

13

5

8

 

Expression of VEGF

   

0.025*

    No

39

26

13

 

  Yes

43

18

25

 

Expression of CDX2

   

0.202

  No

11

8

3

 

  Yes

73

38

35

 

Expression of Her2

   

0.316

  No

64

32

32

 

  Yes

19

12

7

Â